We are live on ! Find out more
PRVL

Prevail Therapeutics Inc. Common Stock
PRVL

Delisted

PRVL was delisted on the 21st of January, 2021.

Back to rankings

42 hedge funds and large institutions have $328M invested in Prevail Therapeutics Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 18

11% more funds holding

Funds holding: 38 → 42 (+4)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

6% less capital invested

Capital invested by funds: $349M → $328M (-$21.3M)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

Holders
42
Holders Change
+4
Holders Change %
+10.53%
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
22
Increased
6
Reduced
8
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$7.03M
2
BlackRock
BlackRock
New York
+$3.91M
3
Bank of America
Bank of America
North Carolina
+$2.72M
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$2.38M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.79M

Top Sellers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
-$6.6M
2
DCM
Driehaus Capital Management
Illinois
-$3.35M
3
Millennium Management
Millennium Management
New York
-$1.47M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$1.4M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$142K +$131K +11,559 New
State of Wisconsin Investment Board
27
State of Wisconsin Investment Board
Wisconsin
$139K +$128K +11,300 New
AIG
28
American International Group
New York
$58K +$53.1K +4,684 New
Wells Fargo
29
Wells Fargo
California
$55K +$51K +4,500 New
VMI
30
VHCP Management III
New York
$54K +$50K +4,408 New
Morgan Stanley
31
Morgan Stanley
New York
$53K -$93.3K -8,232 -66%
Barclays
32
Barclays
United Kingdom
$47K +$43.1K +3,803 New
VMI
33
VHCP Management II
New York
$32K +$29.5K +2,604 New
JP Morgan Chase
34
JP Morgan Chase
New York
$30K +$27.6K +2,432 New
Deutsche Bank
35
Deutsche Bank
Germany
$25K +$23.3K +2,059 New
SO
36
STRS Ohio
Ohio
$23K +$21.5K +1,900 New
Victory Capital Management
37
Victory Capital Management
Texas
$16K +$15.2K +1,343 New
Legal & General Group
38
Legal & General Group
United Kingdom
$15K +$13.6K +1,202 New
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$11.5K +$10.6K +938 New
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$10K +$9.06K +800 New
AIP
41
Ameritas Investment Partners
Nebraska
$8K +$6.98K +616 New
Citigroup
42
Citigroup
New York
$5K +$4.38K +387 New
Fidelity International
43
Fidelity International
Bermuda
– -$6.6M -500,000 Closed
DCM
44
Driehaus Capital Management
Illinois
– -$3.35M -253,970 Closed
MIM
45
Monashee Investment Management
Massachusetts
– -$1.19M -90,000 Closed
DKCM
46
Davidson Kempner Capital Management
New York
– -$936K -70,000 Closed
Norges Bank
47
Norges Bank
Norway
– -$792K -60,000 Closed
ACPU
48
Arrowgrass Capital Partners (US)
Delaware
– -$660K -50,000 Closed
DS
49
DRW Securities
Illinois
– -$652K -49,426 Closed
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
– -$615K -41,000 Closed
1
2
3

PRVL Hedge Fund Activity: Q3 2019 in Review

42 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Prevail Therapeutics Inc. Common Stock (PRVL) for Q3 2019, worth a combined $328M — down 6.1% from $349M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new PRVL positions and 18 closed out — a net gain of 4 holders — while 6 added to existing stakes and 8 trimmed.

The largest buyer was RA Capital Management, adding an estimated $7.03M. The largest seller was Fidelity International, exiting entirely with an estimated $6.6M sold.

  • 42 institutional investors held Prevail Therapeutics Inc. Common Stock (PRVL) as of Q3 2019, up from 38 in Q2 2019.
  • Funds reported $328M of Prevail Therapeutics Inc. Common Stock stock for Q3 2019, down 6.1% quarter-over-quarter.
  • 22 funds opened new Prevail Therapeutics Inc. Common Stock positions in Q3 2019 and 18 closed out, a net change of +4 holders.
  • The largest Prevail Therapeutics Inc. Common Stock buyer in Q3 2019 was RA Capital Management, an estimated $7.03M added.
  • The largest Prevail Therapeutics Inc. Common Stock seller in Q3 2019 was Fidelity International, an estimated $6.6M sold.

Based on aggregated 13F filings for Q3 2019.